Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease

Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease

Extended-release ropinirole is a new formulation of the well-known nonergolinic D2/D3 dopamine receptor agonist (DRAs), which has been widely used to treat Parkinson’s disease (PD) in foreign countries for many years. The efficiency of extended-release ropinirole (Requip Modutab) was evaluated in 12...

Full description

Bibliographic Details
Main Authors: Oleg Semenovich Levin, V K Datiyeva
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2013-03-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
parkinson’s disease
extended-release ropinirole
treatment
therapy adherence
Online Access:https://nnp.ima-press.net/nnp/article/view/177

Similar Items

Similar Items